Brugada Syndrome Market - Global Outlook and Forecast 2022-2028

March 2022 | 68 pages | ID: B0497D530271EN
Market Monitor Global

Abstracts

Brugada syndrome is a genetic condition resulting in an abnormal electrical activity within the heart, which in turn increases the risk of sudden cardiac death.

This report contains market size and forecasts of Brugada Syndrome in Global, including the following market information:

Global Brugada Syndrome Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Brugada Syndrome market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Diagnosis Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Brugada Syndrome include GeneDx, PGxHealth, GE Healthcare, Pfizer, Abbott, Medtronic, Boston Scientific and GlaxoSmithKline, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Brugada Syndrome companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Brugada Syndrome Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Brugada Syndrome Market Segment Percentages, by Type, 2021 (%)

• Diagnosis
• Treatment

Global Brugada Syndrome Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Brugada Syndrome Market Segment Percentages, by Application, 2021 (%)

• Adult
• Child

Global Brugada Syndrome Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Brugada Syndrome Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Brugada Syndrome revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Brugada Syndrome revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GeneDx
• PGxHealth
• GE Healthcare
• Pfizer
• Abbott
• Medtronic
• Boston Scientific
• GlaxoSmithKline

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Brugada Syndrome Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Brugada Syndrome Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BRUGADA SYNDROME OVERALL MARKET SIZE

2.1 Global Brugada Syndrome Market Size: 2021 VS 2028
2.2 Global Brugada Syndrome Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Brugada Syndrome Players in Global Market
3.2 Top Global Brugada Syndrome Companies Ranked by Revenue
3.3 Global Brugada Syndrome Revenue by Companies
3.4 Top 3 and Top 5 Brugada Syndrome Companies in Global Market, by Revenue in 2021
3.5 Global Companies Brugada Syndrome Product Type
3.6 Tier 1, Tier 2 and Tier 3 Brugada Syndrome Players in Global Market
  3.6.1 List of Global Tier 1 Brugada Syndrome Companies
  3.6.2 List of Global Tier 2 and Tier 3 Brugada Syndrome Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Brugada Syndrome Market Size Markets, 2021 & 2028
  4.1.2 Diagnosis
  4.1.3 Treatment
4.2 By Type - Global Brugada Syndrome Revenue & Forecasts
  4.2.1 By Type - Global Brugada Syndrome Revenue, 2017-2022
  4.2.2 By Type - Global Brugada Syndrome Revenue, 2023-2028
  4.2.3 By Type - Global Brugada Syndrome Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Brugada Syndrome Market Size, 2021 & 2028
  5.1.2 Adult
  5.1.3 Child
5.2 By Application - Global Brugada Syndrome Revenue & Forecasts
  5.2.1 By Application - Global Brugada Syndrome Revenue, 2017-2022
  5.2.2 By Application - Global Brugada Syndrome Revenue, 2023-2028
  5.2.3 By Application - Global Brugada Syndrome Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Brugada Syndrome Market Size, 2021 & 2028
6.2 By Region - Global Brugada Syndrome Revenue & Forecasts
  6.2.1 By Region - Global Brugada Syndrome Revenue, 2017-2022
  6.2.2 By Region - Global Brugada Syndrome Revenue, 2023-2028
  6.2.3 By Region - Global Brugada Syndrome Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Brugada Syndrome Revenue, 2017-2028
  6.3.2 US Brugada Syndrome Market Size, 2017-2028
  6.3.3 Canada Brugada Syndrome Market Size, 2017-2028
  6.3.4 Mexico Brugada Syndrome Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Brugada Syndrome Revenue, 2017-2028
  6.4.2 Germany Brugada Syndrome Market Size, 2017-2028
  6.4.3 France Brugada Syndrome Market Size, 2017-2028
  6.4.4 U.K. Brugada Syndrome Market Size, 2017-2028
  6.4.5 Italy Brugada Syndrome Market Size, 2017-2028
  6.4.6 Russia Brugada Syndrome Market Size, 2017-2028
  6.4.7 Nordic Countries Brugada Syndrome Market Size, 2017-2028
  6.4.8 Benelux Brugada Syndrome Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Brugada Syndrome Revenue, 2017-2028
  6.5.2 China Brugada Syndrome Market Size, 2017-2028
  6.5.3 Japan Brugada Syndrome Market Size, 2017-2028
  6.5.4 South Korea Brugada Syndrome Market Size, 2017-2028
  6.5.5 Southeast Asia Brugada Syndrome Market Size, 2017-2028
  6.5.6 India Brugada Syndrome Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Brugada Syndrome Revenue, 2017-2028
  6.6.2 Brazil Brugada Syndrome Market Size, 2017-2028
  6.6.3 Argentina Brugada Syndrome Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Brugada Syndrome Revenue, 2017-2028
  6.7.2 Turkey Brugada Syndrome Market Size, 2017-2028
  6.7.3 Israel Brugada Syndrome Market Size, 2017-2028
  6.7.4 Saudi Arabia Brugada Syndrome Market Size, 2017-2028
  6.7.5 UAE Brugada Syndrome Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 GeneDx
  7.1.1 GeneDx Corporate Summary
  7.1.2 GeneDx Business Overview
  7.1.3 GeneDx Brugada Syndrome Major Product Offerings
  7.1.4 GeneDx Brugada Syndrome Revenue in Global Market (2017-2022)
  7.1.5 GeneDx Key News
7.2 PGxHealth
  7.2.1 PGxHealth Corporate Summary
  7.2.2 PGxHealth Business Overview
  7.2.3 PGxHealth Brugada Syndrome Major Product Offerings
  7.2.4 PGxHealth Brugada Syndrome Revenue in Global Market (2017-2022)
  7.2.5 PGxHealth Key News
7.3 GE Healthcare
  7.3.1 GE Healthcare Corporate Summary
  7.3.2 GE Healthcare Business Overview
  7.3.3 GE Healthcare Brugada Syndrome Major Product Offerings
  7.3.4 GE Healthcare Brugada Syndrome Revenue in Global Market (2017-2022)
  7.3.5 GE Healthcare Key News
7.4 Pfizer
  7.4.1 Pfizer Corporate Summary
  7.4.2 Pfizer Business Overview
  7.4.3 Pfizer Brugada Syndrome Major Product Offerings
  7.4.4 Pfizer Brugada Syndrome Revenue in Global Market (2017-2022)
  7.4.5 Pfizer Key News
7.5 Abbott
  7.5.1 Abbott Corporate Summary
  7.5.2 Abbott Business Overview
  7.5.3 Abbott Brugada Syndrome Major Product Offerings
  7.5.4 Abbott Brugada Syndrome Revenue in Global Market (2017-2022)
  7.5.5 Abbott Key News
7.6 Medtronic
  7.6.1 Medtronic Corporate Summary
  7.6.2 Medtronic Business Overview
  7.6.3 Medtronic Brugada Syndrome Major Product Offerings
  7.6.4 Medtronic Brugada Syndrome Revenue in Global Market (2017-2022)
  7.6.5 Medtronic Key News
7.7 Boston Scientific
  7.7.1 Boston Scientific Corporate Summary
  7.7.2 Boston Scientific Business Overview
  7.7.3 Boston Scientific Brugada Syndrome Major Product Offerings
  7.7.4 Boston Scientific Brugada Syndrome Revenue in Global Market (2017-2022)
  7.7.5 Boston Scientific Key News
7.8 GlaxoSmithKline
  7.8.1 GlaxoSmithKline Corporate Summary
  7.8.2 GlaxoSmithKline Business Overview
  7.8.3 GlaxoSmithKline Brugada Syndrome Major Product Offerings
  7.8.4 GlaxoSmithKline Brugada Syndrome Revenue in Global Market (2017-2022)
  7.8.5 GlaxoSmithKline Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Brugada Syndrome Market Opportunities & Trends in Global Market
Table 2. Brugada Syndrome Market Drivers in Global Market
Table 3. Brugada Syndrome Market Restraints in Global Market
Table 4. Key Players of Brugada Syndrome in Global Market
Table 5. Top Brugada Syndrome Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Brugada Syndrome Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Brugada Syndrome Revenue Share by Companies, 2017-2022
Table 8. Global Companies Brugada Syndrome Product Type
Table 9. List of Global Tier 1 Brugada Syndrome Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Brugada Syndrome Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Brugada Syndrome Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Brugada Syndrome Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Brugada Syndrome Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Brugada Syndrome Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Brugada Syndrome Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Brugada Syndrome Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Brugada Syndrome Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Brugada Syndrome Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Brugada Syndrome Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Brugada Syndrome Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Brugada Syndrome Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Brugada Syndrome Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Brugada Syndrome Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Brugada Syndrome Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Brugada Syndrome Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Brugada Syndrome Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Brugada Syndrome Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Brugada Syndrome Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Brugada Syndrome Revenue, (US$, Mn), 2023-2028
Table 30. GeneDx Corporate Summary
Table 31. GeneDx Brugada Syndrome Product Offerings
Table 32. GeneDx Brugada Syndrome Revenue (US$, Mn), (2017-2022)
Table 33. PGxHealth Corporate Summary
Table 34. PGxHealth Brugada Syndrome Product Offerings
Table 35. PGxHealth Brugada Syndrome Revenue (US$, Mn), (2017-2022)
Table 36. GE Healthcare Corporate Summary
Table 37. GE Healthcare Brugada Syndrome Product Offerings
Table 38. GE Healthcare Brugada Syndrome Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer Corporate Summary
Table 40. Pfizer Brugada Syndrome Product Offerings
Table 41. Pfizer Brugada Syndrome Revenue (US$, Mn), (2017-2022)
Table 42. Abbott Corporate Summary
Table 43. Abbott Brugada Syndrome Product Offerings
Table 44. Abbott Brugada Syndrome Revenue (US$, Mn), (2017-2022)
Table 45. Medtronic Corporate Summary
Table 46. Medtronic Brugada Syndrome Product Offerings
Table 47. Medtronic Brugada Syndrome Revenue (US$, Mn), (2017-2022)
Table 48. Boston Scientific Corporate Summary
Table 49. Boston Scientific Brugada Syndrome Product Offerings
Table 50. Boston Scientific Brugada Syndrome Revenue (US$, Mn), (2017-2022)
Table 51. GlaxoSmithKline Corporate Summary
Table 52. GlaxoSmithKline Brugada Syndrome Product Offerings
Table 53. GlaxoSmithKline Brugada Syndrome Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Brugada Syndrome Segment by Type in 2021
Figure 2. Brugada Syndrome Segment by Application in 2021
Figure 3. Global Brugada Syndrome Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Brugada Syndrome Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Brugada Syndrome Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Brugada Syndrome Revenue in 2021
Figure 8. By Type - Global Brugada Syndrome Revenue Market Share, 2017-2028
Figure 9. By Application - Global Brugada Syndrome Revenue Market Share, 2017-2028
Figure 10. By Region - Global Brugada Syndrome Revenue Market Share, 2017-2028
Figure 11. By Country - North America Brugada Syndrome Revenue Market Share, 2017-2028
Figure 12. US Brugada Syndrome Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Brugada Syndrome Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Brugada Syndrome Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Brugada Syndrome Revenue Market Share, 2017-2028
Figure 16. Germany Brugada Syndrome Revenue, (US$, Mn), 2017-2028
Figure 17. France Brugada Syndrome Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Brugada Syndrome Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Brugada Syndrome Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Brugada Syndrome Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Brugada Syndrome Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Brugada Syndrome Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Brugada Syndrome Revenue Market Share, 2017-2028
Figure 24. China Brugada Syndrome Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Brugada Syndrome Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Brugada Syndrome Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Brugada Syndrome Revenue, (US$, Mn), 2017-2028
Figure 28. India Brugada Syndrome Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Brugada Syndrome Revenue Market Share, 2017-2028
Figure 30. Brazil Brugada Syndrome Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Brugada Syndrome Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Brugada Syndrome Revenue Market Share, 2017-2028
Figure 33. Turkey Brugada Syndrome Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Brugada Syndrome Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Brugada Syndrome Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Brugada Syndrome Revenue, (US$, Mn), 2017-2028
Figure 37. GeneDx Brugada Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. PGxHealth Brugada Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GE Healthcare Brugada Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer Brugada Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Abbott Brugada Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Medtronic Brugada Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Boston Scientific Brugada Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. GlaxoSmithKline Brugada Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)